au.\*:("SKARIN, Arthur T")
Results 1 to 13 of 13
Selection :
Recent advances in the molecular biology, diagnosis and novel therapies for various small blue cell tumorsPISICK, Evan; SKARIN, Arthur T; SALGIA, Ravi et al.Anticancer research. 2003, Vol 23, Num 4, pp 3379-3396, issn 0250-7005, 18 p.Article
Role of serum tumor markers CA 125 and CEA in non-small cell lung cancerRAVISALGIA; HARPOLE, David; HERNDON, James E et al.Anticancer research. 2001, Vol 21, Num 2B, pp 1241-1246, issn 0250-7005Article
Lung cancer in patients under age 40SKARIN, Arthur T; HERBST, Roy S; LEONG, Traci L et al.Lung cancer. 2001, Vol 32, Num 3, pp 255-264, issn 0169-5002Article
Malignant pleural mesotheliomaHO, Linus; SUGARBAKER, David J; SKARIN, Arthur T et al.Cancer treatment and research. 2001, Vol 105, pp 327-373, issn 0927-3042Article
Haptoglobin α-subunit and hepatocyte growth factor can potentially serve as serum tumor biomarkers in Small cell lung cancerBHARTI, Ajit; MA, Patrick C; MAULIK, Gautam et al.Anticancer research. 2004, Vol 24, Num 2C, pp 1031-1038, issn 0250-7005, 8 p.Article
Phase I trial of the matrix metalloproteinase inhibitor marimastat combined with carboplatin and paclitaxel in patients with advanced non-small cell lung cancerGOFFIN, John R; ANDERSON, Ian C; SUPKO, Jeffrey G et al.Clinical cancer research. 2005, Vol 11, Num 9, pp 3417-3424, issn 1078-0432, 8 p.Article
Circulating tumor cells and serum tumor biomarkers in small cell lung cancerMA, Patrick C; BLASZKOWSKY, Lawrence; BHARTI, Ajit et al.Anticancer research. 2003, Vol 23, Num 1A, pp 49-62, issn 0250-7005, 14 p.Article
Induction docetaxel and carboplatin followed by weekly docetaxel and carboplatin with concurrent radiotherapy, then surgery in stage III non-small cell lung cancer: A Phase I studyWIRTH, Lori J; LUCCA, Joan; LUKANICH, Jeanne M et al.Clinical cancer research. 2003, Vol 9, Num 5, pp 1698-1704, issn 1078-0432, 7 p.Article
Improved Prognosis of Diffuse Histiocytic and Undifferentiated Lymphoma by Use of High Dose Methotrexate Alternating With Standard Agents (M-BACOD)SKARIN, Arthur T; CANELLOS, George P; ROSENTHAL, David S et al.CANELLOS, George P; Journal of clinical oncology. 2008, Vol 26, Num 12, issn 0732-183X, c85-c92, 1913-1914 [10 p.]Article
Phase ii clinical trial of chemotherapy-naive patients ≥ 70 years of age treated with erlotinib for advanced non-small-cell lung cancerJACKMAN, David M; YEAP, Beow Y; FREIDLIN, Boris et al.Journal of clinical oncology. 2007, Vol 25, Num 7, pp 760-766, issn 0732-183X, 7 p.Article
Radiofrequency ablation of thoracic lesions: Part 2, initial clinical experience: Technical and multidisciplinary considerations in 30 patientsVANSONNENBERG, Eric; SHANKAR, Sridhar; SUGARBAKER, David J et al.American journal of roentgenology (1976). 2005, Vol 184, Num 2, pp 381-390, issn 0361-803X, 10 p.Article
Outcomes of patients with advanced non-small cell lung cancer treated with gefitinib (ZD1839, 'Iressa') on an expanded access studyJÄNNE, Pasi A; GURUBHAGAVATULA, Sarada; YEAP, Beow Y et al.Lung cancer. 2004, Vol 44, Num 2, pp 221-230, issn 0169-5002, 10 p.Article
Gemcitabine and vinorelbine in patients with advanced lung cancer: preclinical studies and report of a phase I trialHERBST, Roy S; LYNCH, Cathleen; SALGIA, Ravi et al.Cancer chemotherapy and pharmacology. 2001, Vol 48, Num 2, pp 151-159, issn 0344-5704Article